CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes

Growth and survival of chronic B-cell tumors are favored by the malignant cell's capacity to respond to selected microenvironmental stimuli provided by nontumoral bystander cells. To investigate which mechanisms operate in these crosstalks and whether they are malignancy-related or reproduce the mechanisms used by normal B cells we have studied the expression and functional role of semaphorin CD100 (now called Sema4D) in chronic lymphocytic leukemia (CLL) cells and normal CD5(+) B cells. We demonstrate here that (1) leukemic and normal CD5(+) B lymphocytes uniformly express CD100; (2) the CD100 high-affinity receptor Plexin-B1 is expressed by bone marrow stromal cells, follicular dendritic cells, and activated T lymphocytes, and is thus available to CD100(+) lymphocytes indifferent specific microenvironments; and (3) upon interaction between CD100 and Plexin-B1 both CLL and normal CD5(+) B cells increase their proliferative activity and extend their life span. These findings establish that Plexin-B1 is an easily accessible receptor for CD100 within the immune system. The encounter of CD100(+) leukemic cells with Plexin-B1 may promote the proliferation and survival of malignant cells. The crosstalk operated by. the CD100/Plexin-B1 interaction is not malignancy related but reproduces a mechanism used by normal CD5(+) B cells.